Virtual Reality and Savoring to Promote Well-being of Patients With Chronic Respiratory Diseases: a Randomized Controlled Trial

Not Applicable

Completed

• Conditions: Chronic respiratory diseases; emotional well-being; psychological well-being; Respiratory - Other respiratory disorders / diseases; Mental Health - Studies of normal psychology, cognitive function and behaviour

• Registration Number: ACTRN12624000435583
• Lead Sponsor: IRCCS INRCA (Italian National Research Centre on Aging) Casatenovo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-09-15
• Study Start: 2024-04-09
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

Age 18 years and over
- A diagnosis of chronic respiratory disease according to European Respiratory Society (ERS)/American Thoracic Society (ATS) criteria
- Written informed consent

Exclusion Criteria

- Diagnosis of dementia or cognitive impairment reported within the medical records
- Mini Mental State Examination score of < 26
- Pre-existing medical conditions that preclude the use of the Oculus Quest 2 headset, such as (1) the presence of binocular vision abnormalities, (2) a positive history of seizures and epileptic conditions, (3) the presence of cardiac pacemakers, defibrillators, or implanted devices, and (4) the presence of hearing aids

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Emotional well-being and psychological well-being[Mental Health Continuum Short Form Baseline (T0), immediately after the completion of all four sessions (T1, primary timepoint), and in the one-month follow-up (T2) for both groups];Positive affect and negative affect[Scale of Positive and Negative Experiences Baseline (T0), immediately after the completion of all four sessions (T1, primary timepoint), and in the one-month follow-up (T2) for both groups];Relaxation[10-point Visual Analogue Scale Baseline (T0), immediately after the completion of all four sessions (T1, primary timepoint), and in the one-month follow-up (T2) for both groups]

Secondary Outcome Measures

Name	Time	Method
Sense of presence in the virtual environment[Slater Usoh Steed Presence Questionnaire Immediately after the completion of all four sessions (T1)];VR acceptance[Ad hoc questionnaire based on the Unified Theory of Acceptance and Use of Technology (UTAUT) model designed specifically for this study Immediately after the completion of all four sessions (T1)];Relaxation[10-point Visual Analogue Scale Immediately before and after each of the four sessions];Peripheral oxygen saturation (SpO2)[NONIN Palm Saturimeter Immediately before and after each of the four sessions]